Fed Governor Adriana Kugler to resign
Dawn Christine Maroney, President of Alignment Healthcare, Inc. (NASDAQ:ALHC), recently sold a portion of her holdings in the company. According to a recent SEC filing, Maroney sold 11,152 shares of the company’s common stock on March 27, 2025. The shares were sold at a weighted-average price of $17.89, with individual transaction prices ranging from $17.50 to $18.05. The stock, which has delivered an impressive 269% return over the past year, currently trades near its 52-week high of $18.44. This sale was primarily to cover tax withholding obligations associated with the vesting of restricted stock units and does not represent a discretionary trade. According to InvestingPro data, the company currently has a market capitalization of $3.5 billion, though analysts do not anticipate profitability this year. Following the transaction, Maroney retains ownership of 2,362,899 shares in the company.
In other recent news, Alignment Healthcare has reported strong financial results for the fourth quarter of 2024, surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of -0.16, beating the forecast of -0.18, and reported revenue of $701.2 million, exceeding the projected $674.97 million. This performance marks a significant milestone as Alignment Healthcare reached its first year of adjusted EBITDA profitability. The company’s total revenue for the year was $2.7 billion, a 48% increase compared to the previous year.
Additionally, Alignment Healthcare’s membership grew by 59% in 2024, with notable expansion outside of California. Looking forward, the company has issued revenue guidance for 2025, projecting figures between $3.72 billion and $3.78 billion, and expects adjusted gross profit to range from $415 million to $445 million. Analyst firms have shown confidence in the company, with Piper Sandler raising its price target to $21 and maintaining an Overweight rating, while Raymond (NSE:RYMD) James increased its price target to $19 and reiterated a Strong Buy rating. These developments reflect a positive outlook for Alignment Healthcare’s future growth and profitability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.